7/20/14

Altered Level of Consciousness

Altered Level of Consciousness (ALOC)
Clinical Findings
Neuro: Confused, lethargic, obtunded, stuporous, or comatose.
Resp: Depressed (likely opioid OD), Cheyne-Stokes (likely CVA), Kussmaul’s respirations or fruity odor on breath (likely DKA), apneustic (likely brainstem injury), odor of alcohol (likely intoxicated), sweet almond odor (likely cyanide exposure).
CV: Increased BP and decreased HR (likely ↑ ICP), hypotension (likely sepsis, MI, OD, internal bleeding), dysrhythmias.
Skin: Cool and moist (likely hypoglycemia, vasovagal response, MI, shock), warm and flushed (likely spinal injury, hyperglycemia, sepsis).
GI/GU: Nausea and vomiting, incontinence.
MS:Weakness, fatigue, abnormal flexion or extension, trauma.
Nursing Interventions
Place Pt in position of comfort and offer reassurance. If Pt is unable to maintain airway or clear secretions, place Pt into lateral-lying position and suction airway as needed. Consider inserting oropharyngeal airway, or, if Pt has gag reflex and there is no evidence of facial trauma, use nasopharyngeal airway.
Administer supplemental oxygen titrated to SpO2 >90% and be prepared to ventilate Pt manually if RR <8 breaths/minute.
Assess pupils and establish baseline GCS score.
Assess for neuro deficits such as slurred speech, facial droop, or weakness or numbness on one side of the body.
Obtain and document baseline VS (HR, RR, BP, temp, SpO2).
Palpate radial pulse for rate and rhythm. If Pt is monitored, assess ECG and manage dysrhythmias per ACLS protocol.
Obtain STAT bedside blood glucose level.
Review medication administration record and recent labs for possible causes of ALOC (see AEIOU-TIPS, page 36).
Administer STAT medication if ordered: Glucose 25 g IV for hypoglycemia; naloxone 0.4–2 mg IV for narcotic OD; flumazenil 0.2 mg
for benzodiazepine OD.
Notify physician of change in Pt status including pertinent assessment findings and interventions, if any implemented.
Consult physician about continued treatment, including ordering STAT 12-lead ECG, labs (CBC, electrolytes, coagulation studies, medication levels) additional pharmacologic therapy (e.g., insulin drip, reversal agents, restoring electrolyte imbalances), and/or transfer to ICU.
Document assessments, any interventions, and outcome.

0 comments:

Post a Comment